Sézary's disease
From Wikipedia, the free encyclopedia
| ICD-10 | C84.1 |
|---|---|
| ICD-9 | 202.2 |
| ICD-O: | M9701/3 |
| DiseasesDB | 8595 |
Sézary's disease (or "Sézary syndrome") is a type of cutaneous lymphoma characterized by Albert Sézary.
"Sézary's cells" are T-cells that have pathological quantities of mucopolysaccharides.
Sézary's disease is sometimes considered a late stage of mycosis fungoides.
Vorinostat (Zolinza®) is a second-line drug for CTCL. Treatments are often used in combination.
Vorinostat (Zolinza®) is a second-line drug for CTCL. Treatments are often used in combination.
[edit] External links
- Illustration of Sezary cells
- Illustration of Sezary cells
- Biography of Sezary (in French)
- synd/3594 at Who Named It
- Sezary Syndrome lymphoma information
- Doctor's doctor
- Cutaneous Lymphoma Foundation
- [http://www.clinicaltrials.gov/ct/show/NCT00106431 Clinical Trial for Sezary Syndrome using
- [http://www.zolinza.com
Depsipeptide]
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
